\-\ Texto\\:\\ \ \(0\)\
\-\ anticoagulation\ \(74\)\
\-\ v\\/q\\ study\\ with\\ 44\\ mci\\ tc99m\\ dtpa\\,\\ aerosolized\\ to\\ deliver\\ 1\\ mci\\,\\ and\\ 8\\.8\\ mci\\ tc99m\\ macroaggregated\\ albumin\\ \\(maa\\)\\,\\ demonstrates\\ decreased\\ counts\\ in\\ the\\ apical\\,\\ posterior\\,\\ and\\ anterior\\ segments\\ of\\ the\\ right\\ upper\\ lobe\\ on\\ the\\ posterior\\ perfusion\\ image\\.\\ \\ additionally\\,\\ there\\ are\\ decreased\\ counts\\ in\\ the\\ lateral\\ segment\\ of\\ the\\ right\\ middle\\ lobe\\.\\ \\ these\\ findings\\ are\\ also\\ demonstrated\\ on\\ the\\ rpo\\ and\\ lpo\\ perfusion\\ images\\.\\ \\ additionally\\,\\ best\\ seen\\ on\\ the\\ left\\ lateral\\,\\ anterior\\,\\ and\\ lao\\ perfusion\\ images\\ there\\ are\\ decreased\\ counts\\ in\\ the\\ apical\\ posterior\\ and\\ anterior\\ segments\\ of\\ the\\ left\\ upper\\ lobe\\.\\ \\ the\\ ventilation\\ scan\\ is\\ normal\\.\\ \\ \ \(0\)\
\-\ as\\ there\\ are\\ at\\ least\\ 2\\ large\\ mismatched\\ perfusion\\ defects\\ without\\ any\\ ventilation\\ abnormalities\\,\\ and\\ using\\ the\\ pioped\\ ii\\ v\\/q\\ scan\\ interpretation\\ categories\\ and\\ criteria\\,\\ these\\ findings\\ are\\ most\\ consistent\\ with\\ a\\ high\\-probability\\ v\\/q\\ scan\\.\ \(0\)\
\-\ the\\ corresponding\\ chest\\ radiograph\\ does\\ not\\ show\\ focal\\ abnormalities\\.\\ \\ no\\ secondary\\ signs\\ of\\ embolism\\,\\ such\\ as\\ pleural\\ effusion\\,\\ oligemia\\,\\ or\\ apparent\\ hilar\\ enlargement\\,\\ can\\ be\\ seen\\.\ \(0\)\
\-\ high\\-probability\\ v\\/q\\ study\\ for\\ pulmonary\\ embolus\ \(0\)\
\-\ differential\\ diagnosis\\ of\\ conditions\\ associated\\ with\\ ventilation\\-perfusion\\ mismatch\\:\ \(0\)\
\-\ acute\\ pulmonary\\ embolus\ \(0\)\
\-\ chronic\\ pulmonary\\ embolus\ \(0\)\
\-\ other\\ causes\\ of\\ embolism\\ \\(drug\\ abuse\\,\\ iatrogenic\\)\ \(0\)\
\-\ bronchogenic\\ carcinoma\\ \\(other\\ neoplasms\\)\ \(0\)\
\-\ mediastinal\\ or\\ hilar\\ adenopathy\\ with\\ obstruction\\ of\\ pulmonary\\ artery\\ or\\ veins\ \(1\)\
\-\ hypoplasia\\ or\\ aplasia\\ of\\ pulmonary\\ artery\ \(0\)\
\-\ swyer\\-james\\ syndrome\\ \\(some\\ cases\\)\ \(0\)\
\-\ post\\-radiation\\ therapy\ \(0\)\
\-\ vasculitis\ \(67\)\
\-\ 62\\ yo\\ male\\ with\\ pmhx\\ significant\\ for\\ prostate\\ cancer\\ treated\\ with\\ xrt\\,\\ chronic\\ renal\\ insufficiency\\,\\ and\\ prior\\ left\\ lower\\ extremity\\ deep\\ venous\\ thrombosis\\ presents\\ with\\ acute\\ shortness\\ of\\ breath\\ after\\ being\\ diagnosed\\ with\\ a\\ right\\ lower\\ extremity\\ deep\\ venous\\ thrombosis\\.\ \(0\)\
\-\ other\\ information\\:\\ \\ using\\ the\\ wells\\ prediction\\ rule\\ for\\ diagnosing\\ pulmonary\\ embolism\\,\\ this\\ patient\\ had\\ a\\ score\\ greater\\ than\\ 7\\,\\ placing\\ him\\ at\\ a\\ high\\-pretest\\ probability\\ of\\ having\\ a\\ pulmonary\\ embolism\\.\ \(0\)\
\-\ this\\ case\\ is\\ an\\ example\\ of\\ an\\ atypical\\ distribution\\ for\\ pulmonary\\ embolus\\,\\ as\\ pulmonary\\ emboli\\ preferentially\\ are\\ found\\ in\\ the\\ lower\\ lung\\ segments\\.\\ \\ here\\,\\ the\\ upper\\ lobes\\ are\\ predominately\\ affected\\.\\ \\ the\\ differential\\ diagnosis\\ includes\\ a\\ lung\\ mass\\ versus\\ mediastinal\\ or\\ hilar\\ adenopathy\\ with\\ obstruction\\ of\\ pulmonary\\ artery\\ or\\ veins\\.\\ \\ however\\,\\ the\\ multiplicity\\ of\\ large\\ multi\\-focal\\ mismatched\\ defects\\ favors\\ the\\ high\\-probability\\ interpretation\\.\\ \\ the\\ high\\ probability\\ v\\/q\\ scan\\ coupled\\ with\\ the\\ high\\ pretest\\ probability\\ of\\ pe\\,\\ allows\\ the\\ clinican\\ to\\ recommend\\ a\\ prolonged\\ course\\ of\\ anticoagulation\\ therapy\\ for\\ this\\ patient\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ v\\/q\\:\\ 0\\.07603818899488303\ \(0\)\
\-\ high\\-probability\\:\\ 0\\.062669562255686\ \(0\)\
\-\ pulmonary\\:\\ 0\\.059159959957821404\ \(0\)\
\-\ embolus\\:\\ 0\\.0488337135339986\ \(0\)\
\-\ perfusion\\:\\ 0\\.04610686924535612\ \(0\)\
\-\ counts\\:\\ 0\\.04390849119207042\ \(0\)\
\-\ probability\\:\\ 0\\.04252823516523897\ \(0\)\
\-\ embolism\\:\\ 0\\.03962833588376173\ \(0\)\
\-\ mci\\:\\ 0\\.03950773852567546\ \(0\)\
\-\ mismatched\\:\\ 0\\.035209592714912835\ \(0\)\
\-\ segments\\:\\ 0\\.034181411649767963\ \(0\)\
\-\ hilar\\:\\ 0\\.03052414583116676\ \(0\)\
\-\ tc99m\\:\\ 0\\.028945347027792834\ \(0\)\
\-\ interpretation\\:\\ 0\\.028945347027792834\ \(0\)\
\-\ ventilation\\:\\ 0\\.024666353134228786\ \(0\)\
\-\ apical\\:\\ 0\\.023335062207847732\ \(0\)\
\-\ scan\\:\\ 0\\.022675558866663306\ \(0\)\
\-\ macroaggregated\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ maa\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ high\\-pretest\\:\\ 0\\.02088985408522867\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.020453595988797316\ \(0\)\
\-\ veins\\:\\ 0\\.019375026565185582\ \(0\)\
\-\ are\\:\\ 0\\.019322552387931784\ \(0\)\
\-\ aerosolized\\:\\ 0\\.019247325221342544\ \(0\)\
\-\ rpo\\:\\ 0\\.019247325221342544\ \(0\)\
\-\ lpo\\:\\ 0\\.019247325221342544\ \(0\)\
\-\ ventilation\\-perfusion\\:\\ 0\\.019247325221342544\ \(0\)\
\-\ post\\-radiation\\:\\ 0\\.019247325221342544\ \(0\)\
\-\ clinican\\:\\ 0\\.019247325221342544\ \(0\)\
\-\ defects\\:\\ 0\\.018602698084098316\ \(0\)\
\-\ mismatch\\:\\ 0\\.018286507429617037\ \(0\)\
\-\ multi\\-focal\\:\\ 0\\.018286507429617037\ \(0\)\
\-\ pretest\\:\\ 0\\.018286507429617037\ \(0\)\
\-\ artery\\:\\ 0\\.018089075773281036\ \(0\)\
\-\ decreased\\:\\ 0\\.01806224930846843\ \(0\)\
\-\ adenopathy\\:\\ 0\\.018032621468579348\ \(0\)\
\-\ deliver\\:\\ 0\\.017604796357456418\ \(0\)\
\-\ pioped\\:\\ 0\\.017604796357456418\ \(0\)\
\-\ swyer\\-james\\:\\ 0\\.017604796357456418\ \(0\)\
\-\ using\\:\\ 0\\.01758091445528871\ \(0\)\
\-\ additionally\\:\\ 0\\.017552277893886043\ \(0\)\
\-\ thrombosis\\:\\ 0\\.0173839997495405\ \(0\)\
\-\ mediastinal\\:\\ 0\\.017194941318131485\ \(0\)\
\-\ lao\\:\\ 0\\.017076020169508054\ \(0\)\
\-\ wells\\:\\ 0\\.017076020169508054\ \(0\)\
\-\ prediction\\:\\ 0\\.017076020169508054\ \(0\)\
\-\ 8\\.8\\:\\ 0\\.01664397856573091\ \(0\)\
\-\ oligemia\\:\\ 0\\.01664397856573091\ \(0\)\
\-\ preferentially\\:\\ 0\\.01664397856573091\ \(0\)\
\-\ deep\\:\\ 0\\.01639304336158524\ \(0\)\
\-\ lobe\\:\\ 0\\.016345914795664933\ \(0\)\
\-\ multiplicity\\:\\ 0\\.016278692594576268\ \(0\)\
\-\ anterior\\:\\ 0\\.015645446614427044\ \(0\)\
\-\ \\,\\:\\ 0\\.015395833109987907\ \(0\)\
\-\ aplasia\\:\\ 0\\.015207637798976607\ \(0\)\
\-\ coupled\\:\\ 0\\.015001449701844782\ \(0\)\
\-\ abnormalities\\:\\ 0\\.014875661714209558\ \(0\)\
\-\ favors\\:\\ 0\\.014811775039111283\ \(0\)\
\-\ extremity\\:\\ 0\\.014811179950912029\ \(0\)\
\-\ venous\\:\\ 0\\.014700405774678339\ \(0\)\
\-\ upper\\:\\ 0\\.014659340085559608\ \(0\)\
\-\ dtpa\\:\\ 0\\.014636163730690143\ \(0\)\
\-\ placing\\:\\ 0\\.014636163730690143\ \(0\)\
\-\ obstruction\\:\\ 0\\.014281516817959411\ \(0\)\
\-\ or\\:\\ 0\\.014239659937872618\ \(0\)\
\-\ posterior\\:\\ 0\\.014002169777505558\ \(0\)\
\-\ other\\:\\ 0\\.014002169777505558\ \(0\)\
\-\ categories\\:\\ 0\\.0137909624417358\ \(0\)\
\-\ xrt\\:\\ 0\\.0137909624417358\ \(0\)\
\-\ lower\\:\\ 0\\.013662526559458738\ \(0\)\
\-\ recommend\\:\\ 0\\.01345977300482784\ \(0\)\
\-\ study\\:\\ 0\\.01332526709412303\ \(0\)\
\-\ albumin\\:\\ 0\\.013079814118393767\ \(0\)\
\-\ score\\:\\ 0\\.013079814118393767\ \(0\)\
\-\ predominately\\:\\ 0\\.012993634866804016\ \(0\)\
\-\ diagnosing\\:\\ 0\\.012910480080521385\ \(0\)\
\-\ differential\\:\\ 0\\.012857629522999667\ \(0\)\
\-\ allows\\:\\ 0\\.012464858678855651\ \(0\)\
\-\ iatrogenic\\:\\ 0\\.012333176567114393\ \(0\)\
\-\ pmhx\\:\\ 0\\.011977057602542501\ \(0\)\
\-\ abuse\\:\\ 0\\.011766281569328057\ \(0\)\
\-\ lung\\:\\ 0\\.01173061194425946\ \(0\)\
\-\ chronic\\:\\ 0\\.011407533805246447\ \(0\)\
\-\ example\\:\\ 0\\.011148446824154473\ \(0\)\
\-\ him\\:\\ 0\\.01110991478417395\ \(0\)\
\-\ high\\:\\ 0\\.011083156687567847\ \(0\)\
\-\ criteria\\:\\ 0\\.011071999283353\ \(0\)\
\-\ 62\\:\\ 0\\.011071999283353\ \(0\)\
\-\ hypoplasia\\:\\ 0\\.011034680901911911\ \(0\)\
\-\ information\\:\\ 0\\.011034680901911911\ \(0\)\
\-\ emboli\\:\\ 0\\.010961762279478844\ \(0\)\
\-\ therapy\\:\\ 0\\.010827681498770678\ \(0\)\
\-\ prostate\\:\\ 0\\.010755574182347022\ \(0\)\
\-\ insufficiency\\:\\ 0\\.010755574182347022\ \(0\)\
\-\ prolonged\\:\\ 0\\.010755574182347022\ \(0\)\
\-\ bronchogenic\\:\\ 0\\.010690647703228267\ \(0\)\
\-\ here\\:\\ 0\\.010565899519613524\ \(0\)\
\-\ these\\:\\ 0\\.010539548303117726\ \(0\)\
\-\ 44\\:\\ 0\\.01039028821119238\ \(0\)\
\-\ drug\\:\\ 0\\.01039028821119238\ \(0\)\
\-\ vasculitis\\:\\ 0\\.010362244472692374\ \(0\)\
\-\ corresponding\\:\\ 0\\.010307133424909751\ \(0\)\
\-\ neoplasms\\:\\ 0\\.010307133424909751\ \(0\)\
\-\ least\\:\\ 0\\.010149096992448441\ \(0\)\
\-\ conditions\\:\\ 0\\.010073863110186404\ \(0\)\
\-\ acute\\:\\ 0\\.009999428100030783\ \(0\)\
\-\ versus\\:\\ 0\\.009625422352749134\ \(0\)\
\-\ having\\:\\ 0\\.009301349042049158\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009299617681423792\ \(0\)\
\-\ as\\:\\ 0\\.009188939615361097\ \(0\)\
\-\ distribution\\:\\ 0\\.009113045318460895\ \(0\)\
\-\ pe\\:\\ 0\\.009096646164800768\ \(0\)\
\-\ there\\:\\ 0\\.00904063191799755\ \(0\)\
\-\ apparent\\:\\ 0\\.008953947444438079\ \(0\)\
\-\ lobes\\:\\ 0\\.008923370655727398\ \(0\)\
\-\ large\\:\\ 0\\.008855651335692322\ \(0\)\
\-\ segment\\:\\ 0\\.008833938598896005\ \(0\)\
\-\ atypical\\:\\ 0\\.008776138946943022\ \(0\)\
\-\ affected\\:\\ 0\\.008761906662440151\ \(0\)\
\-\ lateral\\:\\ 0\\.008751981258884125\ \(0\)\
\-\ ii\\:\\ 0\\.008733695992993899\ \(0\)\
\-\ for\\:\\ 0\\.008638722140316529\ \(0\)\
\-\ findings\\:\\ 0\\.008620080264407392\ \(0\)\
\-\ best\\:\\ 0\\.008519342651393777\ \(0\)\
\-\ shortness\\:\\ 0\\.008519342651393777\ \(0\)\
\-\ rule\\:\\ 0\\.008456147753094816\ \(0\)\
\-\ includes\\:\\ 0\\.008163223686821885\ \(0\)\
\-\ enlargement\\:\\ 0\\.008034522290249042\ \(0\)\
\-\ seen\\:\\ 0\\.008002974478993794\ \(0\)\
\-\ causes\\:\\ 0\\.007882892648838416\ \(0\)\
\-\ pleural\\:\\ 0\\.007863389096382218\ \(0\)\
\-\ images\\:\\ 0\\.007769023184594096\ \(0\)\
\-\ 7\\:\\ 0\\.00775889781708074\ \(0\)\
\-\ effusion\\:\\ 0\\.007694724929396686\ \(0\)\
\-\ course\\:\\ 0\\.007641069771221899\ \(0\)\
\-\ greater\\:\\ 0\\.007605962932868486\ \(0\)\
\-\ breath\\:\\ 0\\.007571368621443954\ \(0\)\
\-\ diagnosed\\:\\ 0\\.0074459600871919565\ \(0\)\
\-\ middle\\:\\ 0\\.007405589975456014\ \(0\)\
\-\ signs\\:\\ 0\\.0071264832558911246\ \(0\)\
\-\ being\\:\\ 0\\.0070563696132714656\ \(0\)\
\-\ does\\:\\ 0\\.006909054669156414\ \(0\)\
\-\ the\\:\\ 0\\.006879703741175691\ \(0\)\
\-\ \\(\\:\\ 0\\.006847030580510526\ \(0\)\
\-\ this\\:\\ 0\\.006832729004602842\ \(0\)\
\-\ left\\:\\ 0\\.006796956890565744\ \(0\)\
\-\ \\)\\:\\ 0\\.006763390446571612\ \(0\)\
\-\ cases\\:\\ 0\\.006745997308012163\ \(0\)\
\-\ cancer\\:\\ 0\\.006656789725982857\ \(0\)\
\-\ a\\:\\ 0\\.006578669698412818\ \(0\)\
\-\ radiograph\\:\\ 0\\.006450115293652518\ \(0\)\
\-\ right\\:\\ 0\\.006409704093202014\ \(0\)\
\-\ found\\:\\ 0\\.006381577285431546\ \(0\)\
\-\ any\\:\\ 0\\.006376386334294535\ \(0\)\
\-\ such\\:\\ 0\\.006330172487774532\ \(0\)\
\-\ image\\:\\ 0\\.006325092811131756\ \(0\)\
\-\ show\\:\\ 0\\.006216009323439873\ \(0\)\
\-\ some\\:\\ 0\\.00614911908499232\ \(0\)\
\-\ yo\\:\\ 0\\.006093250055219815\ \(0\)\
\-\ renal\\:\\ 0\\.006084065283075994\ \(0\)\
\-\ treated\\:\\ 0\\.006061257905411989\ \(0\)\
\-\ demonstrated\\:\\ 0\\.005941753512931203\ \(0\)\
\-\ syndrome\\:\\ 0\\.005791247812167398\ \(0\)\
\-\ focal\\:\\ 0\\.0057831601993801\ \(0\)\
\-\ carcinoma\\:\\ 0\\.005739165094824329\ \(0\)\
\-\ secondary\\:\\ 0\\.005661208451442672\ \(0\)\
\-\ however\\:\\ 0\\.005638312927955144\ \(0\)\
\-\ an\\:\\ 0\\.005600307413671706\ \(0\)\
\-\ at\\:\\ 0\\.0054870291603394935\ \(0\)\
\-\ significant\\:\\ 0\\.005445135429038444\ \(0\)\
\-\ \\:\\:\\ 0\\.0053567526824202134\ \(0\)\
\-\ than\\:\\ 0\\.005305802973739986\ \(0\)\
\-\ prior\\:\\ 0\\.005199319365408445\ \(0\)\
\-\ on\\:\\ 0\\.0051461446376689195\ \(0\)\
\-\ consistent\\:\\ 0\\.004965161774481524\ \(0\)\
\-\ chest\\:\\ 0\\.004845329384022557\ \(0\)\
\-\ 1\\:\\ 0\\.004818308928814472\ \(0\)\
\-\ associated\\:\\ 0\\.00477834730309882\ \(0\)\
\-\ without\\:\\ 0\\.004767803711749195\ \(0\)\
\-\ most\\:\\ 0\\.004674964790824825\ \(0\)\
\-\ can\\:\\ 0\\.004592943963196847\ \(0\)\
\-\ case\\:\\ 0\\.00443010529115467\ \(0\)\
\-\ demonstrates\\:\\ 0\\.004423272989699493\ \(0\)\
\-\ had\\:\\ 0\\.004369312367868977\ \(0\)\
\-\ 2\\:\\ 0\\.0043604371955226215\ \(0\)\
\-\ after\\:\\ 0\\.00418957630950048\ \(0\)\
\-\ of\\:\\ 0\\.004141130360118072\ \(0\)\
\-\ presents\\:\\ 0\\.004136597856653853\ \(0\)\
\-\ patient\\:\\ 0\\.0040596773977080005\ \(0\)\
\-\ in\\:\\ 0\\.003994286541613791\ \(0\)\
\-\ also\\:\\ 0\\.003991989558460075\ \(0\)\
\-\ male\\:\\ 0\\.0036616244973636807\ \(0\)\
\-\ and\\:\\ 0\\.0034124929996629094\ \(0\)\
\-\ normal\\:\\ 0\\.003174437096206401\ \(0\)\
\-\ be\\:\\ 0\\.0031226462638481735\ \(0\)\
\-\ not\\:\\ 0\\.002926110596544871\ \(0\)\
\-\ mass\\:\\ 0\\.002816258310302286\ \(0\)\
\-\ with\\:\\ 0\\.0027726108078172922\ \(0\)\
\-\ is\\:\\ 0\\.0026648852056148135\ \(0\)\
\-\ no\\:\\ 0\\.0020389671817625642\ \(0\)\
\-\ to\\:\\ 0\\.0020240194712937737\ \(0\)\
\-\ \\.\\:\\ 0\\.0012618318518014078\ \(0\)\
